Retrieve available abstracts of 4 articles: HTML format
Single Articles
June 2025
WL-SEHRAWY AAMA, Mukhlif MY, Khalaf AA, Uthirapathy S, et al Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate
cancer.
Semin Oncol. 2025;52:152375. PubMedAbstract available
October 2024
YAKOUT IA, Gallab MM, Mohamed DA, Hamdar H, et al Efficacy of metformin drug in preventing metabolic syndrome associated with
androgen deprivation therapy (ADT) in prostate cancer patients: A systematic
review and meta-analysis.
Semin Oncol. 2024 Oct 29:S0093-7754(24)00053. PubMedAbstract available
May 2024
LEUVA H, Moran G, Jamaleddine N, Meseha M, et al Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with
immune checkpoint inhibitors in US Veterans with prostate cancer.
Semin Oncol. 2024 May 11:S0093-7754(24)00037. PubMedAbstract available
September 2023
LONGORIA O, Beije N, de Bono JS PARP inhibitors for prostate cancer.
Semin Oncol. 2023 Sep 25:S0093-7754(23)00062. PubMedAbstract available